bw 58c has been researched along with mephenytoin in 1 studies
| Studies (bw 58c) | Trials (bw 58c) | Recent Studies (post-2010) (bw 58c) | Studies (mephenytoin) | Trials (mephenytoin) | Recent Studies (post-2010) (mephenytoin) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 580 | 35 | 32 |
| Protein | Taxonomy | bw 58c (IC50) | mephenytoin (IC50) |
|---|---|---|---|
| Cytochrome P450 2C19 | Homo sapiens (human) | 1.185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, MD; Dickins, M; Weaver, RJ | 1 |
1 other study(ies) available for bw 58c and mephenytoin
| Article | Year |
|---|---|
Hydroxylation of the antimalarial drug 58C80 by CYP2C9 in human liver microsomes: comparison with mephenytoin and tolbutamide hydroxylations.
Topics: Antimalarials; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Kinetics; Mephenytoin; Microsomes, Liver; Naphthoquinones; Steroid 16-alpha-Hydroxylase; Tolbutamide | 1995 |